World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
23330
World Ranking
14721
National Ranking
7446

Mark F. Munsell publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mark F. Munsell sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 362 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mark F. Munsell D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mark F. Munsell sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mark F. Munsell is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily centers on medicine, with a significant focus on surgery, oncology, epidemiology, genetics, and cardiology and cardiovascular medicine. This multidisciplinary approach informs their work across several aspects of cancer treatment, surgical outcomes, and genetic risk assessment.

The main topics explored in their publications include:

  • Cervical Cancer and HPV Research
  • Enhanced Recovery After Surgery
  • BRCA Gene Mutations in Cancer
  • Cardiac, Anesthesia and Surgical Outcomes
  • Endometrial and Cervical Cancer Treatments
  • Colorectal and Anal Carcinomas
  • Social Media in Health Education

Mark F. Munsell has contributed to numerous academic journals. Frequent publication venues include:

  • International Journal of Gynecological Cancer
  • Gynecologic Oncology
  • Journal of Clinical Oncology
  • Value in Health
  • JMIR Formative Research

Among their recent papers are several influential studies:

  • "Remotely Delivered Cancer Genetic Testing in the Making Genetic Testing Accessible (MAGENTA) Trial" (2023) published in JAMA Oncology
  • "A prospective randomized trial comparing liposomal bupivacaine vs standard bupivacaine wound infiltration in open gynecologic surgery on an enhanced recovery pathway" (2020) published in American Journal of Obstetrics and Gynecology
  • "A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer" (2022) published in Journal of Gastrointestinal Oncology
  • "Thirty-day hospital readmission rate, reasons, and risk factors after acute inpatient cancer rehabilitation" (2021) published in Cancer Medicine
  • "Results from MAGENTA: A national randomized four-arm noninferiority trial evaluating pre- and post-test genetic counseling during online testing for breast and ovarian cancer genetic risk." (2020) published in Journal of Clinical Oncology

Mark F. Munsell frequently collaborates with several co-authors in their research endeavors. These include:

  • Larissa A. Meyer
  • Maria D. Iniesta
  • Pedro T. Ramírez
  • Kathleen M. Schmeler
  • Gabriel E. Mena

Best Publications

  • Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

    Joe Y Chang;Suresh Senan;Marinus A. Paul;Reza John Mehran

  • Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome

    Kathleen M. Schmeler;Henry T. Lynch;Lee-May Chen;Mark F. Munsell

  • Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms

    Jeanne S. Mandelblatt;Kathleen A. Cronin;Stephanie Bailey;Donald A. Berry

  • Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging.

    Eng Hen Ng;Raphael E. Pollock;Mark F. Munsell;Edward N. Atkinson

  • Quality of Life and Sexual Functioning in Cervical Cancer Survivors

    Michael Frumovitz;Charlotte C Sun;Leslie R. Schover;Mark F. Munsell

  • Cord-blood engraftment with ex vivo mesenchymal-cell coculture.

    Marcos J.G. de Lima;Ian McNiece;Simon N. Robinson;Mark Munsell

  • Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

    Marcos De Lima;Athanasios Anagnostopoulos;Mark Munsell;Munir Shahjahan

  • Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non–Small-Cell Lung Cancer

    James Welsh;Ritsuko Komaki;Arya Amini;Mark F. Munsell

  • Body Mass Index and Breast Cancer Risk According to Postmenopausal Estrogen-Progestin Use and Hormone Receptor Status

    Mark F. Munsell;Brian L. Sprague;Donald A. Berry;Gary Chisholm

  • Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML

    Zhihong Zeng;Dos D. Sarbassov;Dos D. Sarbassov;Ismael J. Samudio;Karen W. L. Yee

  • Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma

    Brian M. Slomovitz;Yunyun Jiang;Melinda Yates;Pamela Therese Soliman

  • Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma.

    Russell R. Broaddus M.D.;Henry T. Lynch;Lee-may Chen;Molly S. Daniels

  • Role of Detection Method in Predicting Breast Cancer Survival: Analysis of Randomized Screening Trials

    Yu Shen;Ying Yang;Lurdes Y. T. Inoue;Mark F. Munsell

  • NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells

    Claudia P. Miller;Kechen Ban;Melanie E. Dujka;David J. McConkey

  • A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma

    Brian M. Slomovitz;Brian M. Slomovitz;Karen H. Lu;Taren Johnston;Robert L. Coleman

  • Her-2/neu Overexpression and Amplification in Uterine Papillary Serous Carcinoma

    Brian M. Slomovitz;Russell R. Broaddus;Thomas W. Burke;Nour Sneige

  • Synovial Sarcoma of Childhood and Adolescence: A Multicenter, Multivariate Analysis of Outcome

    Mehmet Fatih Okcu;Mark Munsell;Joern Treuner;Adrian Mattke

  • Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival.

    Suhendan Ekmekcioglu;Julie Ellerhorst;Christine M. Smid;Victor G. Prieto

  • Delays in cancer diagnosis in underinsured young adults and older adolescents.

    Sean Martin;Corinne Ulrich;Corinne Ulrich;Mark Munsell;Sarah Taylor

  • Long-Term Silicone Central Venous Catheters Impregnated With Minocycline and Rifampin Decrease Rates of Catheter-Related Bloodstream Infection in Cancer Patients: A Prospective Randomized Clinical Trial

    Hend Hanna;Robert Benjamin;Ioannis Chatzinikolaou;Badie Alakech

Frequent Co-Authors

Pedro Tomas Ramirez
Pedro Tomas Ramirez The University of Texas MD Anderson Cancer Center
Karen H. Lu
Karen H. Lu The University of Texas MD Anderson Cancer Center
Colin P. Dinney
Colin P. Dinney The University of Texas MD Anderson Cancer Center
Richard E. Champlin
Richard E. Champlin The University of Texas MD Anderson Cancer Center
Ashish M. Kamat
Ashish M. Kamat The University of Texas MD Anderson Cancer Center
H. Barton Grossman
H. Barton Grossman The University of Texas MD Anderson Cancer Center
Wassim Kassouf
Wassim Kassouf McGill University
Russell Broaddus
Russell Broaddus University of North Carolina at Chapel Hill
David M. Gershenson
David M. Gershenson The University of Texas MD Anderson Cancer Center
Elizabeth J. Shpall
Elizabeth J. Shpall The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine but aren’t ready for medical school, there are many online healthcare degrees that offer excellent career pathways. For registered nurses looking to advance, pursuing a dnp program without clinical hours provides an option to gain a terminal degree with more scheduling flexibility. This can accelerate professional growth without an intense on-site commitment.

Those wishing to enter the nursing field quickly can explore fast track lpn programs that allow you to earn a nursing license in less time than traditional routes. If you’re drawn to mental health, the fastest psychiatric nurse practitioner program enables RNs to rapidly specialize and meet the growing need for mental health professionals.

Not all healthcare pathways require direct patient care. If you’re interested in leadership and policy, pursuing one of the best online mha programs can prepare you for management roles in medical settings. Exploring these varied online programs can help you find a career path aligned with your skills and ambitions.

Best Scientists Citing Mark F. Munsell

Trending Scientists

Recently Published Articles